Woodline Partners’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.88M | Sell |
205,510
-204,490
| -50% | -$2.87M | 0.02% | 665 |
|
|
2025
Q1 | $6.41M | Buy |
+410,000
| New | +$6.41M | 0.04% | 444 |
|
|
2023
Q4 | – | Sell |
-1,104,244
| Closed | -$5.86M | – | 480 |
|
|
2023
Q3 | $5.86M | Buy |
1,104,244
+296,494
| +37% | +$1.57M | 0.07% | 298 |
|
|
2023
Q2 | $7.7M | Buy |
807,750
+112,075
| +16% | +$1.07M | 0.09% | 240 |
|
|
2023
Q1 | $7.65M | Buy |
695,675
+50,776
| +8% | +$559K | 0.1% | 235 |
|
|
2022
Q4 | $9.54M | Buy |
644,899
+94,503
| +17% | +$1.4M | 0.13% | 218 |
|
|
2022
Q3 | $10.5M | Buy |
+550,396
| New | +$10.5M | 0.15% | 194 |
|